Cyrus Biotechnology to Present its Protein Engineering Capability, Immunogenicity Risk Mitigation, and Best-in-Class IgG Protease Candidate at Hit ID Summit (Business Wire)

Cyrus CSO and co-founder Yifan Song performed a presentation at the Hit ID Summit in Boston, speaking on a few topics including Cyrus’ hybrid AI/screening platform in risk mitigation of protein therapeutics, Cyrus’ IgG protease candidate, and the company’s overall protein engineering capabilities. Check out the article for a summary of the presentation here